Mesentech is a company focused on treating diseases and medical conditions that relate to bone. Founded in 2016, Mesentech is backed by investors that include Charles Hood Foundation, Merck, Creative Destruction Lab, Ontario, and FedDev and is headquartered in Vancouver.